Investor Relations

Mr Blackford is proposed to be appointed as a Non-executive Director on the Allotment Date. Mr Blackford has served as the President and CEO of iRhythm Technologies, Inc., a Nasdaq-listed digital healthcare solutions company focused on the advancement of cardiac care, since October 2021. From September 2017 to September 2021, Mr Blackford held various roles, the most recent one as the COO at Dexcom. From February 2009 to September 2017, Mr Blackford held various roles, the most recent one as the CFO at Nuvasive Inc., a medical device company for minimally invasive spine surgery. From June 1999 to September 2009, Mr Blackford was the director of finance and controller of the dental division at Zimmer Holdings, Inc., a medical device company. Mr Blackford has served as an independent member of the board of directors of Alphatec Holdings, Inc. since October 2017 and Paragon 28, Inc. since August 2022. He is a Certified Public Accountant (inactive) and received dual B.S. degrees in Accounting and Business Administration from Grace College.